Abstract:Abstract Small cell lung carcinoma (SCLC) is prototypical of cancers with exceptional chemoresistance, and metastatic capabilities fueled by remarkable heterogeneity. The cell-extrinsic factors that govern SCLC heterogeneity are poorly understood especially since non-genetic mechanisms are thought to be major contributors to its intratumoral heterogeneity and plasticity. In order to answer the above question, we sought to inquire about the role of tumor microenvironment (TME) in SCLC heterogeneity which is challenged universally by a lack of patient-derived adequate tumor biopsies. Leveraging large tumor sampling performed at rapid autopsies done on 10 different patients who died from SCLC metastatic disease, we developed a multi-omics approach involving spatial transcriptomics (ST) (Whole transcriptomic atlas), bulk whole genome sequencing, and multiplex immunofluorescence (IF) and standard immunohistochemistry (IHC) to better characterize spatially proximate tumor (36 segments), TME (32 segments) and 4 normal segments. Genomically, SCLC characteristic alterations like TP53 (70%) and RB1 (80%) inactivation and MYC (50%)/MYCL (80%) were evident. ST profiling reveals three distinct tumor subtypes corresponding to the known high-Neuroendocrine (NE) and low-NE SCLC subtypes as well as a novel hybrid-NE state with multiple elevated cancer hallmark capabilities and morphological evidence of nesting and budding. High-NE and hybrid-NE subtypes appear to be driven by ASCL1 and the low-NE subtype resembles the SCLC- inflamed subtype. ST profiling of proximate TMEs reveals similar heterogeneity that is closely linked with SCLC-NE heterogeneity at inter-patient and intra-tumoral levels with distinct features and cellular compositions. Specifically, low-NE TME is marked by increased pro and anti-tumor features including B cells, NK cells, M1-macrophages, and evidence of more checkpoint molecules. High-NE TMEs are predominated by a distinct absence of adaptive immune cells and a strong presence of M2 macrophages. Most strikingly the hybrid-NE TME shows a significant enrichment of immunosuppressive cancer-associated fibroblasts with the absence of T and other adaptive immune cells confirmed using IHC and IF. Next, we attempt to narrow down the fibroblast growth factor receptor (FGF) axis as one of the unique TME-driven factor(s) that could groom non-NE features in SCLC fueling their plasticity and heterogeneity. Subsequently using various SCLC cell lines, we demonstrate that in-vitro modulation of FGFR in SCLC may constrain their plasticity by downregulation of NOTCH signaling, MYC, and its downstream effector REST. We describe the remarkable phenotypic heterogeneity of SCLC tumor and TME and demonstrate their interlinking as well as potential translational avenues of leveraging the cellular crosstalk in order to constrain SCLC heterogeneity. Citation Format: Parth Anil Desai, Nobuyuki Takahashi, Yingying Cao, Christopher Schultz, Darryl Nousome, Desiree Tillo, Lakshya Chauhan, Mayank tandon, Rajesh kumar Bhardwaj, Delphine Lissa, Vinodh Rajapakse, Suresh kumar, Yang Zhang, Elmeskini Rajaa, Donna Butcher, Linda Scuito, Jingjing Gong, Brett Schroder, Andrew Warner, Samantha Nichols, Jordan Kimberly, Alejandro Schaffer, Mohit kumar Jolly, Stephen Hewitt, Anish Thomas. Distinct immunosuppressive tumor microenvironment modulates small cell lung carcinoma neuroendocrine phenotypic plasticity and heterogeneity [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 5828.

Single‐cell transcriptome analysis reveals cellular and molecular alterations in small cell lung cancer tumors following chemotherapy

Single‐cell RNA sequencing reveals immune microenvironment of small cell lung cancer‐associated malignant pleural effusion

The Expression Levels and Prognosis of Notch Family in Ten Cases of Small Cell Lung Cancer

Single-Cell Transcriptome Analysis Reveals Changes of Tumor Immune Microenvironment in Oral Squamous Cell Carcinoma After Chemotherapy

Unveiling Chemotherapy's Impact on Lung Cancer through Single-Cell Transcriptomics

Single-Cell RNA Sequencing Reveals Tumor Microenvironment Remodeling after Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer

Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC

Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer

Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer

Abstract 6943: Evolutionary dynamics under chemotherapy in small cell lung cancer: Insights from patient-derived xenotransplant models

Activation of the TGF-β Pathway Enhances the Efficacy of Platinum-Based Chemotherapy in Small Cell Lung Cancer Patients

Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy

Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities

Comparative Study of the Genomic Landscape and Tumor Microenvironment among Large Cell Carcinoma of the Lung, Large Cell Neuroendocrine of the Lung, and Small Cell Lung Cancer

Immunomodulatory Effects of Chemotherapy on Blood Lymphocytes and Survival of Patients with Advanced Non-Small Cell Lung Cancer

Single-Cell RNA Sequencing Reveals Multiple Pathways and the Tumor Microenvironment Could Lead to Chemotherapy Resistance in Cervical Cancer

Aberrant methylation modifications reflect specific drug responses in small cell lung cancer

Abstract 6291: Integrative single-cell tracking of genome evolution and tumor cell plasticity in small cell lung cancer (SCLC)

Abstract 5828: Distinct immunosuppressive tumor microenvironment modulates small cell lung carcinoma neuroendocrine phenotypic plasticity and heterogeneity

Single-cell RNA sequencing reveals microenvironmental infiltration in non-small cell lung cancer with different responses to immunotherapy

Integrative analysis of blood transcriptome profiles in small-cell lung cancer patients for identification of novel chemotherapy resistance-related biomarkers